Myomo shares rise 10.05% premarket after Q3 revenue exceeds estimates despite net loss.

Myomo Inc. (MYO) surged 10.05% in premarket trading, driven by its recent Q3 2025 earnings report, which highlighted strong international growth and revenue exceeding estimates despite a net loss. The company’s third-quarter results, announced one month prior, emphasized strategic progress in international markets and operational efficiency, aligning with the premarket rally as investors reacted positively to the revenue beat and forward-looking guidance. Earlier announcements, including the launch of the MyoPro® 2x and investor day events, provided additional context for the stock’s momentum, though the immediate catalyst was the earnings release. The stock’s performance reflects renewed confidence in Myomo’s ability to scale its wearable robotic technology business globally.